Gold Rate

Nectar Lifesciences Ltd.

BSE: 532649 | NSE: NECLIFE |

Shares falling in the `Trade-to-Trade` or `T-segment` are traded in this series and no intraday is allowed. This means trades can only be settled by accepting or giving the delivery of shares.

Series: BE | ISIN: INE023H01027 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

Nectar Lifesci Nectar Lifesciences Ltd. | BSE 20.47 0.97 (4.97%) | NSE 20.38 0.97 (5.00%) | Trade | Add

BSE Live

Jan 01, 16:01

20.47 0.97 (4.97%)

Volume

AVERAGE VOLUME

5-Day

55,060

10-Day

175,618

30-Day

465,066

108,576

Prev. Close

19.50
Open Price

19.95

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)

NSE Live

Jan 01, 15:51

20.38 0.97 (5.00%)

Volume

AVERAGE VOLUME

5-Day

357,545

10-Day

1,724,832

30-Day

4,608,006

347,667

Prev. Close

19.41
Open Price

19.62

Bid Price (Qty.)
20.38 (40779)
Offer Price (Qty.)
0.00 (0)

Financials

Print/Copy to Excel : Go

Key Financial Ratios of Nectar Lifesciences (in Rs. Cr.)	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21
Per Share Ratios
Basic EPS (Rs.)	-5.07	0.22	-1.00	8.13	-3.26
Diluted EPS (Rs.)	-5.07	0.22	-1.00	8.13	-3.26
Cash EPS (Rs.)	-2.29	2.93	1.63	3.67	-0.57
Book Value [ExclRevalReserve]/Share (Rs.)	42.63	47.68	47.47	48.46	47.30
Book Value [InclRevalReserve]/Share (Rs.)	42.63	47.68	47.47	48.46	47.30
Dividend / Share(Rs.)	0.00	0.00	0.00	0.00	0.00
Revenue from Operations/Share (Rs.)	74.47	75.10	67.94	74.39	68.75
PBDIT/Share (Rs.)	-1.10	7.41	4.37	7.59	5.04
PBIT/Share (Rs.)	-3.88	4.70	1.73	5.05	2.35
PBT/Share (Rs.)	-7.20	0.81	-1.81	1.53	-3.77
Net Profit/Share (Rs.)	-5.07	0.22	-1.00	1.13	-3.26
Profitability Ratios
PBDIT Margin (%)	-1.47	9.86	6.42	10.19	7.32
PBIT Margin (%)	-5.20	6.25	2.54	6.78	3.41
PBT Margin (%)	-9.67	1.08	-2.67	2.05	-5.49
Net Profit Margin (%)	-6.80	0.29	-1.47	1.51	-4.74
Return on Networth / Equity (%)	-11.88	0.46	-2.10	2.32	-6.89
Return on Capital Employed (%)	-8.47	8.65	2.98	8.16	4.10
Return on Assets (%)	-5.55	0.22	-1.02	1.05	-2.96
Total Debt/Equity (X)	0.61	0.59	0.71	0.79	0.79
Asset Turnover Ratio (%)	0.79	0.77	0.67	0.69	62.41
Liquidity Ratios
Current Ratio (X)	1.26	1.50	1.59	1.56	1.25
Quick Ratio (X)	0.54	0.59	0.63	0.69	0.55
Inventory Turnover Ratio (X)	2.05	1.42	1.39	1.41	1.84
Dividend Payout Ratio (NP) (%)	0.00	0.00	0.00	0.00	-1.53
Dividend Payout Ratio (CP) (%)	0.00	0.00	0.00	0.00	-8.69
Earnings Retention Ratio (%)	0.00	0.00	0.00	0.00	101.53
Cash Earnings Retention Ratio (%)	0.00	0.00	0.00	0.00	108.69
Valuation Ratios
Enterprise Value (Cr.)	1,078.15	1,290.98	1,091.93	1,381.53	1,231.93
EV/Net Operating Revenue (X)	0.65	0.77	0.72	0.83	0.80
EV/EBITDA (X)	-43.89	7.77	11.15	8.12	10.91
MarketCap/Net Operating Revenue (X)	0.31	0.40	0.23	0.32	0.27
Retention Ratios (%)	0.00	0.00	0.00	0.00	101.53
Price/BV (X)	0.54	0.63	0.33	0.50	0.39
Price/Net Operating Revenue	0.31	0.40	0.23	0.32	0.27
Earnings Yield	-0.22	0.01	-0.06	0.05	-0.18